HMGA1 Antibody

中文名稱：

HMGA1兔多克隆抗體
貨號(hào)：

CSB-PA230265
規(guī)格：

￥1100
圖片：
Gel: 12%SDS-PAGE, Lysate: 40 μg, Lane: HT-29 cell, Primary antibody: CSB-PA230265(HMGA1 Antibody) at dilution 1/250 dilution, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

Uniprot No.：

P17096
基因名：

HMGA1
別名：

High mobility group (nonhistone chromosomal) protein isoforms I and Y antibody; High mobility group AT hook 1 antibody; High mobility group AT-hook protein 1 antibody; High mobility group protein 1 antibody; High mobility group protein A1 antibody; High mobility group protein HMG-I/HMG-Y antibody; High mobility group protein Ia antibody; High mobility group protein R antibody; HMG R antibody; HMG-I(Y) antibody; HMGA1 antibody; HMGA1_HUMAN antibody; HMGA1A antibody; HMGIY antibody; MGC12816 antibody; MGC4242 antibody; MGC4854 antibody; Nonhistone chromosomal high mobility group protein HMG I/HMG Y antibody
宿主：

Rabbit
反應(yīng)種屬：

Human,Mouse,Rat
免疫原：

Synthetic peptide of Human HMGA1
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:2000-1:5000
WB	1:500-1:2000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions.
基因功能參考文獻(xiàn)：
1. Study reveals HMGA1, a CK2 Substrate, as a drug-resistant target in non-small cell lung cancer (NSCLC). Results delineate the tyrosine kinase inhibitors (TKI) resistance-associated kinase-substrate network, suggesting a potential therapeutic strategy for overcoming TKI-induced resistance in NSCLC. PMID: 28290473
2. HMGA1 overexpression increased FoxO1 mRNA and protein expression in vitro, in cultured HepG2 and HEK-293 cells by binding FoxO1 gene promoter, thereby activating FoxO1 gene transcription. PMID: 29052178
3. High HMGA1 expression is associated with Esophageal Squamous Cell Carcinoma. PMID: 27882471
4. The HMGA1 rs139876191 variant played a key role in a protective mechanism against proliferative diabetic retinopathy by downregulating the expression of vascular endothelial growth factor A (VEGFA), a major activator of neovascularization in diabetic retinopathy. PMID: 27991577
5. results from Transwell and woundhealing experiments indicated that HMGA1 participates cell invasion and migration through the ILK/Akt/GSK3beta pathway PMID: 29152644
6. Thrombocytosis was more prevalent in patients with inflammatory breast cancer (IBC)than in those with non-IBC and it was associated with poor prognosis. GRO and TGF-beta were associated with thrombocytosis in IBC. PMID: 28831670
7. Findings demonstrate that proper subcellular localization of High-mobility group A1 (HMGA1) is important for its function in trophoblast cells, and suggest that aberrant cytoplasmic expression of HMGA1 contributes to the pathogenesis of preeclampsia through impairment of trophoblast migration. PMID: 28345487
8. these results clearly indicate HMGA1 as a key regulator of the autophagic pathway in cancer cells. PMID: 28777374
9. IGF2BP2 protein is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. PMID: 28753127
10. IL-24 inhibits AKT via regulating the HMGA1/miR-222 signaling node in human lung cancer cells and acts as an effective tumor suppressor. PMID: 27602961
11. These data reveal an essential role for the molecular chaperone GRP78 in IGF-IR signaling and implicate the use of GRP78 inhibitors in blocking IGF-IR signaling in hepatoma cells. PMID: 28389416
12. HMGA1 and MMP-11 may play a key role in the proliferation and progression of skin tumors in humans. PMID: 29374701
13. HMGA1 overexpression in adherent A2780 cells increased cancer stem cell properties, including proliferation, spheroid-forming efficiency and the expression of stemness-related genes. In addition, HMGA1 regulated ABCG2 promoter activity through HMGA1-binding sites. PMID: 27561949
14. Studies indicate that pseudogenes of the HMGA1 gene, that codes for the HMGA1a and HMGA1b proteins having a critical role in development and cancer progression. PMID: 26895108
15. study revealed a subset of potential development-associated miRNAs and suggests a novel regulatory axis for myogenesis in which miR-195/497 promote myogenic differentiation by repressing the HMGA1-Id3 pathway. PMID: 28255268
16. Findings demonstrate that a relationship exists between the HMGA1 rs146052672 variant and acute myocardial infarction, suggesting that defects at the HMGA1 locus may play a pathogenetic role. PMID: 27839822
17. SNP rs5498 in ICAM-1 gene and IVS5-13insC variant in HMGA1 gene were not associated with the susceptibility of DR in the Chinese T2DM cohort. PMID: 26717491
18. We show that the chromatin remodeling protein HMGA1 functions as a downstream effector of these biological responses to miR-296-5p and regulates Sox2 expression, a master driver of cell stemness, by modifying chromatin architecture at the Sox2 promoter PMID: 26898758
19. tissue microarray revealed that HMGA1 was expressed in thyroid carcinoma more than that in normal thyroid tissues ; expression of HMGA1 and MMP-2 was identified to be positively correlated . The present study established the first link between HMGA1 and TGF-b1 in the regulation of thyroid cancer proliferation and invasion PMID: 28393241
20. our research indicated an H19-miR138-HMGA1 pathway in regulating the migration and invasion of colon cancer, providing new insight for treatment of colon cancer. PMID: 28358427
21. The results reported here indicate a critical role of HMGA1 in the development of glioblastoma multiforme; its suppression impairs proliferation and self-renewal of brain tumor stem cells PMID: 27486901
22. miR-214 expression was poor while that of HMGA1 was high in cervical and colorectal cancer tissues. miR-214-re-expression or HMGA1 downregulation inhibited proliferation, migration and invasion of cancer cells while miR-214 inhibition had opposite effects. miR-214 was demonstrated to bind to the wild-type 3' untranslated region of HMGA1 but not with its mutant. PMID: 27537384
23. HMGA1 is frequently expressed in cirrhotic tissues and HCCs and its expression is associated with high Edmondson grade and worse prognosis in HCC. PMID: 27855356
24. Studies define a novel HMGA1-MMP-2 pathway involved in a subset of human carcinosarcomas and tumor progression in murine models. PMID: 27001612
25. HMGA1 may function as an oncogene and modulate endometrial cancer cell migration and invasion by activating Wnt/beta-catenin pathway. PMID: 27470368
26. Increased HMGA1 in pulmonary arterial endothelial cells resulting from dysfunctional BMPr2 signaling can transition endothelium to smooth muscle-like cells associated with pulmonary arterial hypertension. PMID: 27045138
27. in splenic hemangioma with t(3;6)(q26;p21), the entire coding region of HMGA1 comes under the control of the TBL1XR1 promoter, bringing about dysregulation of HMGA1 PMID: 26708416
28. This is the first report for the association between HMGA1 and S100A13 expression in the modulation of thyroid cancer growth and invasion. PMID: 27008379
29. Data indicate that the high mobility group A1 (HMGA1) proteomic signature has prognostic value in breast cancer. PMID: 26527623
30. In breast cancer patients, high levels of HMGA1 and CCNE2 expression are associated with the YAP/TAZ signature. PMID: 26265440
31. HMGA1 is overexpressed in human breast carcinomas and its levels are associated with a particular endocrine status. PMID: 26251519
32. Report epigenetic modification of miRNA targets HMGA transcripts on pituitary cells. PMID: 25557289
33. Our data indicates that measuring urine high mobility group AT-hook 1 may serve as a useful diagnostic tool for serous epithelial ovarian cancer. PMID: 25586095
34. The HMGA1 rs146052672 genotype variant had an overall statistically significant effect on increasing the risk of development of type 2 diabetes mellitus in Europeans. (Meta-analysis) PMID: 26296198
35. Somatic mutation of mtDNA was associated with better prognosis of head and neck squamous cell carcinoma. PMID: 24976238
36. Results show that HMGA1 binds CRMP1 promoter and regulates its expression in medulloblastoma cells. PMID: 26009886
37. HMGA1 plays an important role on breast cancer aggressiveness and prognosis and may act as a promising target for prognostic prediction. PMID: 25772486
38. CBX7/HMGA1b/NF-kappaB could take part in the same transcriptional mechanism that finally leads to the regulation of SPP1 gene expression in papillary thyroid carcinoma. PMID: 25595895
39. The results of the present study indicate that miR-26a may be associated with human breast carcinogenesis, which inhibits tumor cell proliferation by targeting HMGA1. PMID: 25755724
40. High expression of HMGA1 along with miR-26a downregulation indicated a worse prognosis for patients with urothelial bladder cancer. PMID: 25455159
41. High HMGA1 expression is associated with colorectal cancer. PMID: 24696416
42. Increased HMGA1 expression in human chondrocytes is associated with increased expression of IGFBP-3. PMID: 23036517
43. HMGA1 plays an important role on NSCLC progression and prognosis and may act as a convictive biomarker for prognostic prediction PMID: 25344216
44. results indicated that miR-142-3p may function as a tumor suppressor by targeting HMGA1 in osteosarcoma PMID: 24803022
45. The prognostic significance of the HMGA-1 antigen was not confirmed in pituitary adenomas with residual tumor growth. PMID: 24452592
46. our data indicate a critical role for HMGA1 in regulating both self-renewal and the symmetric/asymmetric division ratio in cancer stem cells PMID: 24833610
47. HMGA1 is a key molecular switch required by cancer cells for tumor progression and a poorly differentiated, stem-like state. The HMGA1 gene and proteins are expressed at high levels in all aggressive tumors studied to date. Review. PMID: 24684280
48. a differential control exerted by both Oct-1 and Oct-2 in the transcriptional regulation of the HMGA1 gene PMID: 24367622
49. HMGA1 gene variant may have a role in type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population PMID: 24148075
50. Results support a model in which the HMGA1/TAR interaction prevents the binding of transcription-activating cellular co-factors and Tat, subsequently leading to reduced HIV-1 transcription. PMID: 23392246
顯示更多

收起更多
相關(guān)疾病：

A chromosomal aberration involving HMGA1 is found in pulmonary chondroid hamartoma. Translocation t(6;14)(p21;q23-24) with RAD51B.
亞細(xì)胞定位：

Nucleus. Chromosome.
蛋白家族：

HMGA family
數(shù)據(jù)庫(kù)鏈接：

HGNC: 5010

OMIM: 600701

KEGG: hsa:3159

STRING: 9606.ENSP00000308227

UniGene: Hs.518805

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
VDAC1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human, Mouse, Rat